NCT00409929View on ClinicalTrials.gov

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of AEB071

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

July 31, 2006

Conditions
Healthy
Interventions
DRUG

AEB071

Trial Locations (1)

Unknown

Novartis Investigative Site, Bern

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00409929 - A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of AEB071 | Biotech Hunter | Biotech Hunter